ATOS vs. FCX
ATOS (Atossa Therapeutics, Inc.) and FCX (Freeport-McMoRan Inc.) are both stocks. ATOS operates in Biotechnology (Healthcare), while FCX operates in Copper (Basic Materials). Over the past 10 years, ATOS returned -44.06%/yr vs 19.09%/yr for FCX. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
ATOS vs. FCX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATOS achieves a -75.48% return, which is significantly lower than FCX's 26.04% return. Over the past 10 years, ATOS has underperformed FCX with an annualized return of -44.06%, while FCX has yielded a comparatively higher 19.09% annualized return.
ATOS
- 1D
- 4.83%
- 1M
- 2.36%
- 6M
- -61.18%
- YTD
- -75.48%
- 1Y
- -82.42%
- 3Y*
- -48.51%
- 5Y*
- -46.00%
- 10Y*
- -44.06%
- ALL TIME*
- -46.70%
FCX
- 1D
- 1.61%
- 1M
- 4.51%
- 6M
- 5.10%
- YTD
- 26.04%
- 1Y
- 60.50%
- 3Y*
- 15.84%
- 5Y*
- 13.68%
- 10Y*
- 19.09%
- ALL TIME*
- 7.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $108.17K | $241.43K | $394.85K | |
| $906.38M | $912.02M | $914.50M |
ATOS vs. FCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ATOS Atossa Therapeutics, Inc. | -75.48% | -37.51% | 7.28% | 66.51% | -66.97% | 68.42% | -39.49% | 53.92% | -67.31% | -81.56% |
FCX Freeport-McMoRan Inc. | 26.04% | 35.41% | -9.41% | 13.69% | -7.91% | 61.41% | 99.06% | 29.59% | -45.11% | 43.75% |
Correlation
The correlation between ATOS and FCX is 0.11, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.11 |
Correlation (3Y) Balances recent behavior with more history. | 0.20 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.21 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.15 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2012 | 0.13 |
Fundamentals
ATOS:
$21.65M
FCX:
$91.49B
ATOS:
-$4.37
FCX:
$2.04
ATOS:
0.61
FCX:
4.57
ATOS:
$0.00
FCX:
$25.87B
ATOS:
-$12.00K
FCX:
$6.95B
ATOS:
-$29.16M
FCX:
$9.00B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATOS vs. FCX — Risk / Return Rank
ATOS
FCX
ATOS vs. FCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atossa Therapeutics, Inc. (ATOS) and Freeport-McMoRan Inc. (FCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATOS | FCX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.19 | ||
| Sortino ratioReturn per unit of downside risk | -3.45 | ||
| Omega ratioGain probability vs. loss probability | 0.74 | 1.23 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | -0.92 | 2.50 | -3.42 |
| Martin ratioReturn relative to average drawdown | -1.43 | 5.90 | -7.32 |
Loading charts...
Drawdowns
ATOS vs. FCX - Drawdown Comparison
The maximum ATOS drawdown since its inception was -99.99%, which is greater than FCX's maximum drawdown of -92.52%. Use the drawdown chart below to compare losses from any high point for ATOS and FCX.
Loading charts...
Drawdown Indicators
| ATOS | FCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -92.52% | -7.47% |
Max Drawdown (1Y)Largest decline over 1 year | -90.11% | -24.31% | -65.80% |
Max Drawdown (3Y)Largest decline over 3 years | -94.44% | -46.34% | -48.10% |
Max Drawdown (5Y)Largest decline over 5 years | -97.06% | -51.47% | -45.59% |
Max Drawdown (10Y)Largest decline over 10 years | -99.76% | -72.59% | -27.17% |
Current DrawdownCurrent decline from peak | -99.99% | -11.16% | -88.83% |
Average DrawdownAverage peak-to-trough decline | -93.64% | -39.50% | -54.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 57.73% | 10.29% | +47.44% |
Volatility
ATOS vs. FCX - Volatility Comparison
Atossa Therapeutics, Inc. (ATOS) has a higher volatility of 20.99% compared to Freeport-McMoRan Inc. (FCX) at 14.06%. This indicates that ATOS's price experiences larger fluctuations and is considered to be riskier than FCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATOS | FCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.99% | 14.06% | +6.93% |
Volatility (6M)Calculated over the trailing 6-month period | 85.54% | 38.45% | +47.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 86.31% | 49.47% | +36.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.22% | 45.25% | +27.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 156.04% | 48.38% | +107.66% |
Dividends
ATOS vs. FCX - Dividend Comparison
ATOS has not paid dividends to shareholders, while FCX's dividend yield for the trailing twelve months is around 0.82%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ATOS Atossa Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FCX Freeport-McMoRan Inc. | 0.82% | 1.18% | 1.58% | 1.41% | 0.99% | 0.54% | 0.19% | 1.52% | 1.45% | 0.00% | 0.00% | 8.46% |
Financials
ATOS vs. FCX - Financials Comparison
This section allows you to compare key financial metrics between Atossa Therapeutics, Inc. and Freeport-McMoRan Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATOS and FCX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATOS has higher volatility (20.99%) compared to FCX (14.06%). In terms of maximum drawdown, ATOS dropped -99.99% vs FCX's -92.52%.
FCX currently has the higher Sharpe Ratio (1.23 vs -0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATOS and FCX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer